These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation. Wu H; Shi J; Luo Y; Tan Y; Zhang M; Lai X; Yu J; Liu L; Fu H; Huang H; Zhao Y JAMA Netw Open; 2021 Jan; 4(1):e2034750. PubMed ID: 33502484 [TBL] [Abstract][Full Text] [Related]
28. [The clinical characteristics of polyserositis as main presentation of chronic graft-versus-host rejection disease after allogeneic hematopoietic stem cell transplantation]. Wang Q; Li Y; Qiu Z; Xu W; Sun Y; Wang L; Wang M; Liu W; Dong Y; Ou J; Wang W; Liang Z; Wang Q; Cen X; Ren H Zhonghua Nei Ke Za Zhi; 2014 May; 53(5):394-7. PubMed ID: 25146408 [TBL] [Abstract][Full Text] [Related]
29. National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution. Lawitschka A; Gueclue ED; Januszko A; Körmöczi U; Rottal A; Fritsch G; Bauer D; Peters C; Greinix HT; Pickl WF; Kuzmina Z Front Immunol; 2019; 10():1879. PubMed ID: 31507582 [TBL] [Abstract][Full Text] [Related]
30. Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis. Wertheimer T; Dohse M; Afram G; Weber D; Heidenreich M; Holler B; Kattner AS; Neubauer A; Mielke S; Ljungman P; Holler E; Herr W; Edinger M; Martínez AP; Fante M; Wolff D Ann Hematol; 2021 Mar; 100(3):779-787. PubMed ID: 33515310 [TBL] [Abstract][Full Text] [Related]
31. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation. Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028 [TBL] [Abstract][Full Text] [Related]
32. Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD. Andree H; Hilgendorf I; Leithaeuser M; Junghanss C; Holzhueter S; Loddenkemper C; Steiner B; Freund M; Wolff D Bone Marrow Transplant; 2008 Oct; 42(8):541-6. PubMed ID: 18641680 [TBL] [Abstract][Full Text] [Related]
33. [Prophylaxis and treatment of chronic graft versus host disease]. Huang K; Li Y; Huang SL; Fang JP; Zhou DH; Chen C Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):174-7. PubMed ID: 15833186 [TBL] [Abstract][Full Text] [Related]
34. Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients. Diaz MA; Vicent MG; Gonzalez ME; Verdeguer A; de la Rubia J; Bargay J; de Arriba F; Diez JL; Caballero D; Madero L; Brunet S; Bone Marrow Transplant; 2004 Sep; 34(5):433-8. PubMed ID: 15273704 [TBL] [Abstract][Full Text] [Related]
35. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Hovi L; Saarinen-Pihkala UM; Vettenranta K; Saxen H Bone Marrow Transplant; 2000 Nov; 26(9):999-1004. PubMed ID: 11100280 [TBL] [Abstract][Full Text] [Related]
36. [Mycophenolate mofetil in treatment of graft-versus-host disease after allogeneic hematopoietic cell transplantation: analysis of 44 cases]. Chen H; Liu KY; Liu DH; Xu LP; Han W; Chen YH; Huang XJ Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2127-30. PubMed ID: 19080474 [TBL] [Abstract][Full Text] [Related]
37. Long-term Use of Ibrutinib in Japanese Patients with Steroid Dependent/Refractory cGVHD: Final Analysis of Multicenter Study. Toyosaki M; Doki N; Shiratori S; Osumi T; Okada M; Kawakita T; Sawa M; Ishikawa T; Ueda Y; Hatayama T; Yoshinari N; Fujikawa E Blood Cell Ther; 2023 Nov; 6(4):104-113. PubMed ID: 38149026 [TBL] [Abstract][Full Text] [Related]